Abstract
Purpose
To investigate the relationship of ocular blood flow (via arteriovenous passage time, AVP) and contrast sensitivity (CS) in healthy as well as normal tension glaucoma (NTG) subjects.
Design
Mono-center comparative prospective trial
Methods
Twenty-five NTG patients without medication and 25 healthy test participants were recruited. AVP as a measure of retinal blood flow was recorded via fluorescein angiography after CS measurement using digital image analysis. Association of AVP and CS at 4 spatial frequencies (3, 6, 12, and 18 cycles per degree, cpd) was explored with correlation analysis.
Results
Significant differences regarding AVP, visual field defect, intraocular pressure, and CS measurement were recorded in-between the control group and NTG patients. In NTG patients, AVP was significantly correlated to CS at all investigated cpd (3 cpd: r = − 0.432, p< 0.03; 6 cpd: r = − 0.629, p< 0.0005; 12 cpd: r = − 0.535, p< 0.005; and 18 cpd: r = − 0.58, p< 0.001), whereas no significant correlations were found in the control group. Visual acuity was significantly correlated to CS at 6, 12, and 18 cpd in NTG patients (r = − 0.68, p< 0.002; r = − 0.54, p< .02, and r = − 0.88, p< 0.0001 respectively), however not in healthy control patients. Age, visual field defect MD, and PSD were not significantly correlated to CS in in the NTG group. MD and PSD were significantly correlated to CS at 3 cpd in healthy eyes (r = 0.55, p< 0.02; r = − 0.47, p< 0.03).
Conclusion
Retinal blood flow alterations show a relationship with contrast sensitivity loss in NTG patients. This might reflect a disease-related link between retinal blood flow and visual function. This association was not recorded in healthy volunteers.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Glaucoma is one of the leading causes of irreversible blindness in the world [1].
Whereas first described in 1857, glaucoma in absence of elevated intraocular pressure, consequently named normal tension glaucoma, remains not sufficiently understood today [2,3,4]. While often heatedly discussed, ocular hemodynamics are nowadays often accepted as a critical risk factor in glaucoma, particularly in these patients without elevated IOP [5,6,7,8,9,10]
There are two major issues in the discussion about ocular hemodynamics. On one hand, we are still insufficiently able to measure ocular blood flow directly and rely on different surrogates which are related to ocular blood flow depending on the technique used. Furthermore, we don’t know if recorded ocular blood flow alterations in glaucomatous eyes are primary or secondary in nature [11].
Contrast sensitivity (CS) is important in human vision and substantially affects the level of disability experienced by the patient [12,13,14].
It was previously reported that retinal ganglion cells significantly contribute to contrast sensitivity and contrast adaptation [15,16,17]. As glaucoma mainly affects the retinal ganglion cells, significant correlations of decreased GC thickness measured via OCT and CS were reported in glaucoma patients [18].
Furthermore, impairments in CS can be detected particularly early in glaucomatous eyes, even prior to visible retinal nerve fiber layer damage, manifested visual field defects, or a decrease in visual acuity [14, 19, 20]. CS might be a more potent parameter to detect subtle visual disturbances in glaucomatous eyes. A recently published Review highlighted the potential benefits of reliable contrast sensitivity testing in glaucoma for better patient assessment and care [21]. Furthermore, a potential benefit in CS monitoring lies in advanced glaucoma stages, where other structural and functional assessments are not suited to monitor further glaucoma progression [18].
Disturbances in ocular blood flow seem to play a critical role in glaucoma, particularly in normal tension glaucoma (NTG). To date, little is known concerning the association between altered blood flow and visual function in glaucoma. The aim of this study was to investigate if alterations in ocular blood flow are correlated to CS test performance in NTG patients. To verify that this potential relationship (altered blood flow leading to weaker functional performance) only exists in glaucoma patients, a control group of healthy test subjects was recruited.
Methods
Twenty-five patients suffering from NTG (age 55.23 ± 12.15 years, 5 male and 20 female) and twenty-five healthy control subjects (age 43.59 ± 12.41 years, 12 male and 13 female) were included in this study.
All examinations in this study were performed in accordance with the Declaration of Helsinki for research involving human subjects. Informed consent was acquired from each patient and the study was approved by the local ethics committee (EK 123/03) All participants underwent a detailed ophthalmological examination prior to the inclusion in this study. Patients with best-corrected visual acuity > 0.22 LogMAR (< 0.63 decimal) were excluded from the study. Further exclusion criteria were other significant ocular comorbidities that could either influence ocular blood flow or contrast sensitivity testing (e.g., diabetic retinopathy, macular degeneration, optic nerve atrophy by other causes than glaucoma).
Patients with NTG had glaucomatous excavation of the optic disc (i.e., vertical cup-to-disc ratio > 0.6, or CDR asymmetry > 0.2, or presence of focal thinning or notching in compliance with other studies) and a glaucomatous visual field defect as defined by the European Glaucoma Society. The diagnostic criteria for glaucomatous visual field loss are as follows. Field loss was considered significant when (a) glaucoma hemifield test was abnormal, (b) 3 points are confirmed with p < 0.05 probability of being normal (one of which should have p < 0.01), not contiguous with the blind spot, or (c) corrected pattern standard deviation (CPSD) was abnormal with p < 0.05. All parameters were confirmed on two consecutive visual fields performed with Humphrey Field Analyzer. All patients with glaucomatous visual field loss underwent diurnal curves of IOP measurements (Goldmann applanation tonometry) at 8.00 h, 12.00 h, 16.00 h, 20.00 h, and 24.00 h without any topical or systemic IOP-lowering medication. In patients with NTG, diagnosis was confirmed by readings of IOP never above 21 mmHg. All patients had no other serious eye diseases (e.g., age-related macular degeneration, diabetic retinopathy, and vascular occlusive diseases).
Topical antiglaucomatous eye drops were discontinued and washed out in the NTG group for 3 weeks prior to the inclusion into this study. No topical medication was taken by the healthy control patients.
The CSV-1000 (VectorVision, Greenville, OH) was used for CS measurement. The device measures contrast sensitivity at 3, 6, 12, and 18 cycles/degree frequency. The device projects 4 double rows (rows A, B, C, and D) displaying circles of decreasing contrast sensitivity at 3, 6, 12, and 18 cycles/degree, respectively. Each row consists of 17 circles, with the first circle of each row displaying the highest contrast. The remaining 16 circles are presented in 2 rows consisting of 8 pairs of circles. The patient is instructed to choose the one circle out of each pair showing the grid pattern. The last correct response for each level of contrast is defined as the contrast threshold for that spatial frequency [18].
Systemic and diastolic blood pressure and heart rate were recorded after a resting time of 5 min in the supine position before fluorescein angiography.
Fluorescein angiography with a scanning laser ophthalmoscope (Rodenstock, Ottobrunn, Germany) was performed to evaluate the AVP and for digital image analysis. We previously described the technique in greater detail [22]. A 40-degree observation centered on the optic nerve head was used. At the beginning of the angiography, 10% sodium fluorescein dye (2.5 cc Alcon, Freiburg, Germany) was injected into the antecubital vein. Image acquisition was performed with constant parameters until the maximum intensity level in the retinal veins had passed to avoid artifacts. The dynamic sequences were acquired with 25 images per second. The angiograms were analyzed by digital image analysis (Matrox Inspector, Matrox Inc., Quebec, Canada). The retinal AVP was calculated using dye dilution curve analysis. The AVP represents the shortest passage of the fluorescein dye from the retinal arterioles to the venules representing retinal microcirculation. The intensity level for each image was calculated at a predetermined region of interest (ROI) consisting of the arterioles and venules; the extend corresponded to vessel diameter. All measurements were performed in the temporal superior and inferior arterioles and venules. AVP was calculated by an independent investigator blinded to the study groups, and mean AVP was used for further analysis.
Fisher’s transformation was used to find statistically significant correlations between the individual parameters. Unpaired t-test was used for the analysis of the descriptive parameters in both groups. p values were set at 0.05 to be considered statistically significant. Matlab (Version R2018b for Windows) as well as GraphPad Prism (Version 7.0 for Windows) was used for statistical analysis.
Results
Baseline parameters of the two groups are presented in Table 1.
For the NTG patients, statistically significant correlations were computed between AVP and contrast sensitivity at 3 cpd (r = − 0.432, p < 0.03), at 6 cpd (r = − 0.629, p < 0.0005), at 12 cpd (r = − 0.535, p < 0.005), and at 18 cpd (r = − 0.58, p < 0.001) using Fisher’s transformation. Please refer to Fig. 1 for visualization.
No significant correlations were computed between AVP and contrast sensitivity in healthy control subjects (r = 0.069, p > 0.74; r = 0.36, p > 0.07; r = 0.203, p > 0.33; r = 0.205, p > 0.33 respectively).
In neither NTG patients nor healthy control subjects was age significantly correlated to CPD (p > 0.14 in all calculations).
Visual acuity was significantly correlated to CS at 6, 12, and 18 cpd (r = − 0.68, p < 0.002; r = − 0.54, p < 0.02; and r = − 0.88, p < 0.0001 respectively) (please refer to Fig. 2) as well as AVP (r = 0.69, p < 0.002) in NTG patients. Whereas in the healthy control group, visual acuity was only correlated to age (r = 0.56, p < 0.009).
MD and PSD were not significantly correlated to CS at any cpd in NTG patients. However, significant correlations were found in healthy patients between MD and PSD and CS at 3 cpd (r = 0.55, p < 0.02; r = − 0.47, p < 0.03).
Furthermore, AVP was not significantly correlated to MD, PSD, and age in both groups (p > 0.06 always).
Discussion
The aim of this pilot study was to test our hypothesis that altered ocular blood flow in glaucomatous eyes is correlated to alterations in CS.
Our analysis showed significant correlations between AVP and CS in NTG eyes whereas no such correlations existed in the healthy control subjects. Slower blood flow in glaucomatous eyes (represented in increased AVPs) was significantly correlated to worse performance in CS. No significant correlations were computed for AVP and either MD or PSD in our patients.
Our findings highlight a potential direct link between impaired ocular blood flow and visual function in patients with NTG. Reduced ocular blood flow remains an important issue not only in the pathogenesis of NTG, but also with a direct impact on visual disturbances in these patients.
The findings, significant correlations between blood flow and CS but not VF-performance in glaucomatous eyes, highlight that CS and VF present different functional aspects of the human visual system that are often correlated [19, 23] but different in nature [18]. Interestingly, MD and PSD were correlated to CS at 3 cpd in our healthy control patients, whereas no such correlation was computed in the NTG eyes. Better performance in VF testing (represented in higher MD and lower PSD) was accompanied by better performance in CS testing. As this was only significant at 3 cpd, we are inclined to believe that it might be a result of the small sample size.
The potential importance and benefits of CS testing have recently been highlighted in various studies. Fatehi et al. [18] were able to record significant correlations between central VF summary indices and central macular thickness measurements and CS in glaucomatous eyes. Furthermore, Amanullah et al. [24] were able to record a linear relationship with RNFL thickness. Thakur et al. [25] were able to show that contrast sensitivity scores are associated with the severity of glaucomatous disease. Besides, Lin et al. [26] reported that contrast sensitivity is a vital parameter to predict visual disability in glaucoma.
CS testing provides additional important functional information in glaucomatous eyes that can either be used in the early diagnosis of glaucoma or in advanced stages to monitor further disease progression, whereas the currently available conventional diagnostic tools often fail to provide reliable measurements [21]. In our study, neither MD nor PSD were correlated to CS in our glaucoma patients, supporting the thesis that CS testing might open a new avenue in glaucoma diagnosis and follow-up.
Investigations into the associations of altered blood flow and visual function such as CS parameters are sparse to date.
Harris [27] reported in 1999 that accelerated AVP and improved CS at 3 and 6 cycles per degree were recorded in NTG patients receiving topical dorzolamide. The lack of significant improvement at 12 and 18 cpd was attributed to higher between- and within-subject variability in higher frequencies. We were able to show that baseline alterations in AVP are significantly correlated with all frequencies including the higher ones in NTG patients, strengthening the integral association of ocular blood flow and CS.
Similar findings regarding the effect of dorzolamide were previously reported by our group for brinzolamide, a different antiglaucomatous drug, as well [28]. Thirty healthy test subjects were prospectively randomized to either brinzolamide or placebo during a 2-week double-masked treatment trial. IOP was significantly reduced, CS at 3 cpd significantly increased, and AVP significantly reduced under topical treatment. These results highlight that there is an association between IOP, ocular blood flow, and CS.
In the study, reduced IOP resulted in improved CS; accordingly, Owidza et al. [29] reported that patients with elevated IOP suffering from POAG and OHT show significantly reduced CS. As IOP is integral in ocular perfusion, these findings might be a result of improved or rather reduced blood flow.
The importance of ocular blood flow in glaucomatous eyes has been shown in other studies as well. In previous studies, ocular blood flow disturbances showed a significant correlation to the extent of visual field defects in glaucomatous eyes [30, 31]. Some studies were able to find significant correlations between blood flow disturbances and visual field progression to a certain degree [5, 32]. Furthermore, it was reported that retinal blood flow disturbances are correlated to ocular perfusion pressure in normal tension glaucoma patients [6]. Therefore, disturbances in ocular perfusion pressure due to autoregulatory deficiencies seem to result in retinal perfusion alterations in glaucomatous eyes; these disturbances might be the reason for altered performance in demanding functional tasks such as CS testing.
However, the complexity of the issue is exemplified by the findings of Hosking et al. [33]. The authors showed that mild hypercapnia, which is known to improve ocular blood flow, resulted in a significant fall in contrast sensitivity in previously untreated glaucoma patients and did not alter CS in healthy test subjects. One possible explanation may be that baseline blood flow in glaucoma patients is severely altered, and although ocular perfusion increases due to mild hypercapnia, the increase is insufficient to compensate for increased metabolic stress. On the other hand, disturbed autoregulation in glaucoma eyes might not be able to provide sufficient blood flow to compensate for the increased metabolic stress in the Hosking et al. [33] study.
To further complicate the issue of blood flow and glaucoma, Harris et al. [34] reported that middle cerebral artery (MCA) blood flow was significantly correlated to different functional parameters including CS in glaucomatous patients. Intraocular blood flow alterations were not recorded in this study; therefore, it is not known if MCA blood flow was correlated with intraocular blood flow and subsequently ocular function in these patients.
This and other studies highlight how poorly our understanding of glaucoma is to date.
We and other authors are strong believers that glaucoma is a systemic disease that primarily manifests with ocular damage. We were able to differentiate NTG patients from healthy test subjects just by continuous heart rate and blood pressure measurement with high specificity and sensitivity [35]. These studies support our understanding that blood flow alterations, either systemically and/or locally, play a critical role in glaucoma.
Therefore, in the future, it appears necessary that we ophthalmologists start looking in new directions and even beyond the eye in search of a better understanding of glaucoma.
Some limitations in our work have to be mentioned. The patients in both groups were not matched for systemic disease as well as systemic medication. The exact influences of systemic medication on ocular blood flow have not been described in greater detail today. However, various studies reported partially contradicting results on the influence of topical medication on ocular blood flow [36], and this factor was ruled out in our study, by discontinuing the topical medication in all NTG patients. Furthermore, the groups differed significantly in age as well as gender distribution. While we were unable to compute significant correlations of age with either CS or AVP, the influence on both can’t be ruled out completely and it is known that CS performance is age-dependent and a linear decline in CS was recorded in the age group 50 to 87 years [37]. In addition, systemic diseases such as migraine, arterial hypotension, or Raynaud’s phenomenon might be a part of the concept in NTG-associated ocular blood flow alterations. Not only reduced ocular blood flow but also disturbances in autoregulation or vasospasm might affect glaucomatous optic neuropathy. An association between visual function and blood flow, as shown in our study in NTG but not in healthy subjects, might be a hint to this phenomenon [35].
In summary, this study was able to verify that blood flow alterations in untreated NTG patients are significantly correlated to CS function in glaucomatous eyes, whereas no association exists in healthy test subjects. Further studies are necessary to verify that including CS testing as well as blood flow measurement is beneficial in the assessment and care of glaucoma patients.
Code availability
Not applicable.
References
Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267. https://doi.org/10.1136/bjo.2005.081224
Von Graefe A (1857) Amaurose mit Sehnervenexcavation. Archiv Ophthalmol 3:484–486
Hollows FC, Graham PA (1966) Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 50(10):570–586. https://doi.org/10.1136/bjo.50.10.570
Bengtsson B (1981) Aspects of the epidemiology of chronic glaucoma. Acta Ophthalmol Suppl 146:1–48
Koch EC, Arend KO, Bienert M, Remky A, Plange N (2013) Arteriovenous passage times and visual field progression in normal tension glaucoma. Sci World J 2013:726912. https://doi.org/10.1155/2013/726912
Plange N, Kaup M, Remky A, Arend KO (2008) Prolonged retinal arteriovenous passage time is correlated to ocular perfusion pressure in normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol 246(8):1147–1152. https://doi.org/10.1007/s00417-008-0807-6
Plange N, Kaup M, Weber A, Harris A, Arend KO, Remky A (2009) Performance of colour Doppler imaging discriminating normal tension glaucoma from healthy eyes. Eye (Lond) 23(1):164–170. https://doi.org/10.1038/sj.eye.6702943
Plange N, Remky A, Arend O (2003) Colour Doppler imaging and fluorescein filling defects of the optic disc in normal tension glaucoma. Br J Ophthalmol 87(6):731–736. https://doi.org/10.1136/bjo.87.6.731
Arend O, Plange N, Sponsel WE, Remky A (2004) Pathogenetic aspects of the glaucomatous optic neuropathy: fluorescein angiographic findings in patients with primary open angle glaucoma. Brain Res Bull 62(6):517–524. https://doi.org/10.1016/j.brainresbull.2003.07.008
Arend O, Remky A, Cantor LB, Harris A (2000) Altitudinal visual field asymmetry is coupled with altered retinal circulation in patients with normal pressure glaucoma. Br J Ophthalmol 84(9):1008–1012. https://doi.org/10.1136/bjo.84.9.1008
Hayreh SS (2001) Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 20(5):595–624. https://doi.org/10.1016/s1350-9462(01)00005-2
Atkin A, Bodis-Wollner I, Wolkstein M, Moss A, Podos SM (1979) Abnormalities of central contrast sensitivity in glaucoma. Am J Ophthalmol 88(2):205–211. https://doi.org/10.1016/0002-9394(79)90467-7
Ross JE (1985) Clinical detection of abnormalities in central vision in chronic simple glaucoma using contrast sensitivity. Int Ophthalmol 8(3):167–177. https://doi.org/10.1007/BF00136494
Ross JE, Bron AJ, Clarke DD (1984) Contrast sensitivity and visual disability in chronic simple glaucoma. Br J Ophthalmol 68(11):821–827. https://doi.org/10.1136/bjo.68.11.821
Solomon SG, Peirce JW, Dhruv NT, Lennie P (2004) Profound contrast adaptation early in the visual pathway. Neuron 42(1):155–162. https://doi.org/10.1016/s0896-6273(04)00178-3
Duong T, Freeman RD (2007) Spatial frequency-specific contrast adaptation originates in the primary visual cortex. J Neurophysiol 98(1):187–195. https://doi.org/10.1152/jn.01364.2006
Beaudoin DL, Borghuis BG, Demb JB (2007) Cellular basis for contrast gain control over the receptive field center of mammalian retinal ganglion cells. J Neurosci 27(10):2636–2645. https://doi.org/10.1523/jneurosci.4610-06.2007
Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K (2017) Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol 178:129–139. https://doi.org/10.1016/j.ajo.2017.03.019
Wilensky JT, Hawkins A (2001) Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. Trans Am Ophthalmol Soc 99:213–217; discussion 217–218
Regan D, Neima D (1984) Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson’s disease. Br J Ophthalmol 68(12):885–889. https://doi.org/10.1136/bjo.68.12.885
Ichhpujani P, Thakur S, Spaeth GL (2020) Contrast sensitivity and glaucoma. J Glaucoma 29(1):71–75. https://doi.org/10.1097/IJG.0000000000001379
Wolf S, Arend O, Reim M (1994) Measurement of retinal hemodynamics with scanning laser ophthalmoscopy: reference values and variation. Surv Ophthalmol 38(Suppl):S95-100. https://doi.org/10.1016/0039-6257(94)90052-3
Tochel CM, Morton JS, Jay JL, Morrison JD (2005) Relationship between visual field loss and contrast threshold elevation in glaucoma. BMC Ophthalmol 5:22. https://doi.org/10.1186/1471-2415-5-22
Amanullah S, Okudolo J, Rahmatnejad K, Lin SC, Wizov SS, ManziMuhire RS, Hark LA, Zheng CX, Zhan T, Spaeth GL (2017) The relationship between contrast sensitivity and retinal nerve fiber layer thickness in patients with glaucoma. Graefes Arch Clin Exp Ophthalmol 255(12):2415–2422. https://doi.org/10.1007/s00417-017-3789-4
Thakur S, Ichhpujani P, Kumar S, Kaur R, Sood S (2018) Assessment of contrast sensitivity by Spaeth Richman Contrast Sensitivity Test and Pelli Robson Chart Test in patients with varying severity of glaucoma. Eye (Lond) 32(8):1392–1400. https://doi.org/10.1038/s41433-018-0099-y
Lin S, Mihailovic A, West SK, Johnson CA, Friedman DS, Kong X, Ramulu PY (2018) Predicting visual disability in glaucoma with combinations of vision measures. Transl Vis Sci Technol 7(2):22. https://doi.org/10.1167/tvst.7.2.22
Harris A, Arend O, Kagemann L, Garrett M, Chung HS, Martin B (1999) Dorzolamide, visual function and ocular hemodynamics in normal-tension glaucoma. J Ocul Pharmacol Ther 15(3):189–197. https://doi.org/10.1089/jop.1999.15.189
Kaup M, Plange N, Niegel M, Remky A, Arend O (2004) Effects of brinzolamide on ocular haemodynamics in healthy volunteers. Br J Ophthalmol 88(2):257–262. https://doi.org/10.1136/bjo.2003.021485
Owidzka M, Laudanska-Olszewska I, Omulecki W (2016) Contrast sensitivity assessment in primary open angle glaucoma and ocular hypertension. Klin Oczna 118(1):7–10
Plange N, Kaup M, Arend O, Remky A (2006) Asymmetric visual field loss and retrobulbar haemodynamics in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 244(8):978–983. https://doi.org/10.1007/s00417-005-0227-9
Plange N, Kaup M, Huber K, Remky A, Arend O (2006) Fluorescein filling defects of the optic nerve head in normal tension glaucoma, primary open-angle glaucoma, ocular hypertension and healthy controls. Ophthalmic Physiol Opt 26(1):26–32. https://doi.org/10.1111/j.1475-1313.2005.00349.x
Kuerten D, Fuest M, Koch EC, Koutsonas A, Plange N (2015) Retrobulbar hemodynamics and visual field progression in normal tension glaucoma: a long-term follow-up study. Biomed Res Int 2015:158097. https://doi.org/10.1155/2015/158097
Hosking SL, Evans DW, Embleton SJ, Houde B, Amos JF, Bartlett JD (2001) Hypercapnia invokes an acute loss of contrast sensitivity in untreated glaucoma patients. Br J Ophthalmol 85(11):1352–1356. https://doi.org/10.1136/bjo.85.11.1352
Harris A, Siesky B, Zarfati D, Haine CL, Catoira Y, Sines DT, McCranor L, Garzozi HJ (2007) Relationship of cerebral blood flow and central visual function in primary open-angle glaucoma. J Glaucoma 16(1):159–163. https://doi.org/10.1097/01.ijg.0000212290.08540.93
Lindemann F, Kuerten D, Koch E, Fuest M, Fischer C, Voss A, Plange N (2018) Blood pressure and heart rate variability in primary open-angle glaucoma and normal tension glaucoma. Curr Eye Res 43(12):1507–1513. https://doi.org/10.1080/02713683.2018.1506036
Costa VP, Harris A, Stefansson E, Flammer J, Krieglstein GK, Orzalesi N, Heijl A, Renard JP, Serra LM (2003) The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 22(6):769–805. https://doi.org/10.1016/s1350-9462(03)00064-8
Ross JE, Clarke DD, Bron AJ (1985) Effect of age on contrast sensitivity function: uniocular and binocular findings. Br J Ophthalmol 69(1):51–56. https://doi.org/10.1136/bjo.69.1.51
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the local ethics committee.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kuerten, D., Fuest, M., Walter, P. et al. Association of ocular blood flow and contrast sensitivity in normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol 259, 2251–2257 (2021). https://doi.org/10.1007/s00417-021-05235-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05235-8